1996 Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases
Please Choose a Presenter
» Frank O. Bastian, M.D.
» Richard J. Duma, M.D., Ph.D.
» Stuart B. Levy, M.D.
» William J. Martone, M.D., M.Sc.
» Robert W. Pinner, M.D.
» David A. Relman, M.D.
Frank O. Bastian, M.D.
Professor of Pathology
Director of Neuropathology
University of South Alabama
Mobile, AL
Dr. Frank O. Bastian is a professor of pathology and director of neuropathology at the University of South Alabama in Mobile, AL.
He received his medical degree from the University of Saskatchewan and trained in neuropathology at Duke University Medical Center. Following a virology fellowship at the National Institutes of Health where he worked on the latency of herpes simplex virus in the trigeminal ganglia, Bastian moved to Baylor College of Medicine.
He began work on Creutzfeldt-Jakob disease (CJD) at Duke University and continued his investigations in Houston.
Bastian has published numerous research articles relating to the etiology of CJD. In 1991, he edited a book entitled, "Creutzfeldt-Jakob Disease and Other Transmissible Spongiform Encephalopathies."
In 1992, Bastian arranged an international symposium on bovine spongiform encephalopathy, commonly known as "Mad Cow Disease," at the American Society of Microbiology General Meeting held in New Orleans. He has served as a resource for consultation on CJD to fellow pathology colleagues for the past 14 years.
The University of South Alabama is developing a national center for research on CJD to add to Bastian's CJD tissue repository in the department of pathology.
Return to the list of presenters.
Richard J. Duma, M.D., Ph.D.
Director
Division of Infectious Diseases
Halifax Medical Center
Daytona Beach, FL
Dr. Richard J. Duma is director of the Division of Infectious Diseases at the Halifax Medical Center in Daytona Beach, FL. He is also a trustee and one of the founders of the National Foundation for Infectious Diseases (NFID), a nonprofit, public foundation established in 1973, to support research and education into the causes, cures and prevention of infectious diseases. Duma, known internationally in the field of infectious diseases, served as president of the NFID Board of Directors from 1975 to 1991, and as executive director from 1991 to 1995.
Prior to becoming executive director of NFID, Duma was professor of medicine, pathology and microbiology and chairman of the Division of Infectious Diseases at the Medical College of Virginia (MCV). He was also director of hospital epidemiology and chairman of the MCV Hospital Infection Control Committee.
Duma has served as chairman of the Steering Committee for the National Coalition for Adult Immunization (NCAI), which is a national network of more than 85 health care organizations dedicated to promoting adult immunization, primarily through educational and motivational activities. He is the author of more than 100 scientific articles and research studies, more than 30 chapters, and is a reviewer for numerous medical journals.
Duma received his medical degree from the University of Virginia Medical School and his doctorate in experimental pathology and microbiology from Virginia Commonwealth University. He is board-certified in internal medicine and infectious diseases and is a fellow of the American College of Physicians and the Infectious Diseases Society of America.
Return to the list of presenters.
Stuart B. Levy, M.D.
Professor of Medicine and of Molecular Biology and Microbiology
Director of the Center for Adaptation Genetics and Drug Resistance
Tufts University School of Medicine
Boston, MA
Dr. Stuart B. Levy, professor of medicine and of molecular biology and microbiology, is the director of the Center for Adaptation Genetics and Drug Resistance at Tufts University School of Medicine. He also serves as staff physician at the New England Medical Center, and he is president of the Alliance for the Prudent Use of Antibiotics.
Levy is well-known for his contributions to the antibiotic resistance field. He has published over 180 papers on antibiotic use and resistance and has edited three books. In addition, two journals have published special editions devoted to this subject. His 1992 book, "The Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle," has been cited widely in both the lay and scientific media. In the book he stresses increased awareness of the problems of antibiotic misuse and resistance, and he outlines an approach toward improving antibiotic usage and efficacy worldwide.
Levy led the discovery of the first characterized energy-dependent antibiotic efflux mechanism and efflux protein, that for tetracycline resistance. He has written extensively about efflux as a mechanism for drug resistance. His interests have expanded to the phenomenon of multidrug resistance in bacterial and mammalian cells, including the discovery of a regulatory locus mar for intrinsic multiple antibiotic resistance/susceptibility among the Enterobacteriaceae and new efflux systems for chemotherapeutic agents among mammalian cells. Levy is a fellow of the American College of Physicians, the Infectious Diseases Society of America and the American Academy of Microbiology. He has organized and chaired three international meetings on drug resistance and was chairperson of the U.S. Fogarty Center three-year international study of Antibiotic Use and Resistance Worldwide. Levy has been, and continues to be a consultant to international and national organizations and agencies. He has served twice as a member of the Comite Scientifique d'Evaluation of the Pasteur Institut, Paris. He was a member of the advisory panel for the Office of Technology Assessment Report on Antibiotic Resistant Bacteria. Levy was awarded the 1995 Hoechst-Roussel Award for esteemed research in antimicrobial chemotherapy by the American Society for Microbiology.
Return to the list of presenters.
William J. Martone, M.D., M.Sc.
Senior Executive Director
National Foundation for Infectious Diseases
Bethesda, MD
Dr. Martone is the senior executive director of the National Foundation for Infectious Diseases (NFID)--a nonprofit foundation that promotes research, education and prevention of infectious diseases. Prior to NFID, Martone was the director of the Hospital Infections Program at the National Center for Infectious Diseases, Centers for Disease Control and Prevention. In addition, he is a clinical associate professor of medicine at Emory University School of Medicine and a staff physician at the Atlanta V.A. Medical Center and the Washington, D.C., V.A. Medical Center.
Martone currently serves as president of the Society for Healthcare Epidemiology of America. He is a fellow of the Infectious Diseases Society of America and is a member of the American Society for Microbiology, the American College of Physicians, the American College of Epidemiology and numerous national and international scientific program committees. In addition, Martone also is a member of the American Hospital Association Ad Hoc Committee on AIDS Policy as well as the Technical Panel on Infections in Hospitals, and he serves as a consultant to the U.S. Food and Drug Administration.
Martone received his bachelor's degree from Union College in Schenectady, New York, his masters of science from the University of Virginia, and his medical degree from New York University.
Martone has authored and/or coauthored more than 75 research papers and books on infectious disease topics. In addition, as an editorial board member, he has reviewed several scientific journals and numerous proceedings.
Return to the list of presenters.
Robert W. Pinner, M.D.
Special Assistant for Surveillance
Office of the Director
National Center for Infectious Diseases
Centers for Disease Control and Prevention
Atlanta, GA
Dr. Pinner is special assistant for surveillance for the National Center for Infectious Diseases at the Centers for Disease Control and Prevention (CDC), and is clinical assistant professor for the Division of Infectious Diseases at Emory University School of Medicine. As a commander in the U.S. Public Health Service Commissioned Corps, Pinner has consulted widely on various infectious disease outbreaks. In addition, he is involved in activities to implement CDC's plan to address emerging infections. Pinner received his medical degree from Emory University School of Medicine in Atlanta and has published widely in the field of infectious diseases.
Return to the list of presenters.
By David A. Relman, M.D.
Assistant Professor of Medicine and of Microbiology and Immunology
Stanford University School of Medicine
Staff Physician
Veterans Affairs Palo Alto Health Care System
Palo Alto, CA
Dr. Relman received his medical degree from Harvard Medical School and his clinical training in internal medicine and infectious diseases at Massachusetts General Hospital. He then moved to Stanford to work with Dr. Stanley Falkow as postdoctoral fellow in 1986, and joined the faculty at Stanford University in 1992. Relman continues the work he began as a postdoctoral fellow on a much broader scale, examining the molecular mechanisms of Bordetella pertussis adherence to, and interaction with human cells.
Another major area of Relman's current investigation concerns the development and application of molecular methods for identifying and characterizing novel or previously-uncharacterized microbial pathogens. One such method led Relman to identify several important, uncultivated pathogens directly from infected human tissue, including the agents of bacillary angiomatosis and Whipple's disease. Relman is currently studying a number of chronic inflammatory diseases of unknown cause for possible microbial etiology, characterizing a number of newly-identified microbial pathogens and examining bacterial diversity within the human body.
Relman has published a number of research and review articles on the identification of uncultivated microbial pathogens and has recently proposed a revision of Koch's postulates for investigations involving sequence-based microbial identification. He has served as a consultant on these issues for the National Institutes of Health and for the Office of Technology Assessment of the U.S. Congress. He is also a co-organizer of the American Society for Microbiology (ASM) Conferences on Molecular Diagnostics and Therapeutics. Relman received the Baxter Diagnostics MicroScan Young Investigator Award from ASM in 1995.
